Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Targeting Epigenetic Resistance Mechanisms to PI3 Kinase Inhibition in Leukemic Stem Cells

Shira Glushakow-Smith, Imit Kaur, Simone Sidoli, Shayda Hemmati, Ellen Angeles, Taneisha Sinclair, Aaliyah Battle, Amit Verma, Kira Gritsman

Blood (2023) 142 (Supplement 1): 1426.

https://doi.org/10.1182/blood-2023-186796

Published: 2023

Journal Articles

PI3Kinase Alpha and Delta Promote Hematopoietic Stem Activation Under Stress

Shayda Hemmati, PhD, Taneisha Sinclair, Meng Tong, Boris Bartholdy, PhD, Rachel Okabe, MD, Kristina Ames, PhD, Leanne Ostrodka, MD, Tamanna Haque, MD, Imit Kaur, PhD, Anupriya Agarwal, PhD, Jean Zhao, PhD, Thomas Roberts, PhD, Kira Gritsman, MD PhD

Blood (2018) 132 (Supplement 1): 329.

https://doi.org/10.1182/blood-2018-99-114891

Published: 2018

Journal Articles

Examination of Phosphoprotein Targets in Timed Samples from Patients with RAS -Mutated AML during Concurrent Treatment with Alpelisib and Binimetinib on the Phase Ib Clinical Trial CMEK162X2109

Kira Gritsman, MD PhD, Robert P. Hasserjian, MD, Taneisha Sinclair, David M. Weinstock, MD, Britta Will, PhD, Ulrich Steidl, MD PhD, Karen K. Ballen, MD, Amir T. Fathi, MD, Amit Verma, MD, Dejan Juric, MD, Philip C. Amrein, MD

Blood (2016) 128 (22): 2749.

https://doi.org/10.1182/blood.V128.22.2749.2749

Published: 2016

Journal Articles

PI3 Kinase p110 Delta Is Required for Leukemic Cell Survival and Self-Renewal in t(8;21) Acute Myeloid Leukemia

Leanne Ostrodka, MD, Michael Samuel, MD, Taneisha Sinclair, Redwan Bhuiyan, Kira Gritsman, MD PhD

Blood (2016) 128 (22): 1553.

https://doi.org/10.1182/blood.V128.22.1553.1553

Published: 2016

Journal Articles

The Class IA PI3 Kinase Isoforms Have Distinct but Overlapping Roles in Adult Hematopoiesis

Kira Gritsman, MD PhD, Imit Kaur, PhD, Taneisha Sinclair

Blood (2015) 126 (23): 3587.

https://doi.org/10.1182/blood.V126.23.3587.3587

Published: 2015

NARROW

Targeting Epigenetic Resistance Mechanisms to PI3 Kinase Inhibition in Leukemic Stem Cells

PI3Kinase Alpha and Delta Promote Hematopoietic Stem Activation Under Stress

Examination of Phosphoprotein Targets in Timed Samples from Patients with RAS -Mutated AML during Concurrent Treatment with Alpelisib and Binimetinib on the Phase Ib Clinical Trial CMEK162X2109

PI3 Kinase p110 Delta Is Required for Leukemic Cell Survival and Self-Renewal in t(8;21) Acute Myeloid Leukemia

The Class IA PI3 Kinase Isoforms Have Distinct but Overlapping Roles in Adult Hematopoiesis

Email alerts

ASH Publications

American Society of Hematology

Targeting Epigenetic Resistance Mechanisms to PI3 Kinase Inhibition in Leukemic Stem Cells

PI3Kinase Alpha and Delta Promote Hematopoietic Stem Activation Under Stress

Examination of Phosphoprotein Targets in Timed Samples from Patients with RAS -Mutated AML during Concurrent Treatment with Alpelisib and Binimetinib on the Phase Ib Clinical Trial CMEK162X2109

PI3 Kinase p110 Delta Is Required for Leukemic Cell Survival and Self-Renewal in t(8;21) Acute Myeloid Leukemia

The Class IA PI3 Kinase Isoforms Have Distinct but Overlapping Roles in Adult Hematopoiesis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only